Milestone Scientific (NYSE:MLSS) Research Coverage Started at StockNews.com

Investment analysts at StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS – Get Rating) in a research report issued on Tuesday. The brokerage set a “sell” rating on the stock.

Milestone Scientific Trading Up 1.9 %

Shares of MLSS stock opened at $1.05 on Tuesday. Milestone Scientific has a 1 year low of $0.41 and a 1 year high of $1.27. The company has a market cap of $73.50 million, a PE ratio of -9.55 and a beta of 1.38.

Milestone Scientific Company Profile

(Get Rating)

Milestone Scientific, Inc is a biomedical technology research and development company, which patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. It operates through the following segments: Dental, Medical, and Corporate. The Corporate segment refers to executive management, investor relations, patents, trademarks, licensing agreements, new instruments developments, financing activities, and public company compliance costs.